Akin Akinc, Ph.D., Associate Director, Research, Alnylam Pharmaceuticals, Inc.

Kathryn L. Ackley, Ph.D., Vice President, Business Development and Project Management, Girindus, USA

Dr. Hüseyin Aygün, CSO, Nucleic Acid Technologies, BioSpring GmbH, Germany

Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals, USA

Jesse Z. Dong, Ph.D., Vice President, IPSEN/Biomeasure, Incorporated, USA

Takefumi Gemba, Ph.D., Director, Business Development, SNBL, Ltd., Japan

Robert Hagopian, Director, Business Development, PolyPeptide Laboratories, USA

Peter Hoffmann, Ph.D

Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc., USA

Jesper Lau, Ph.D., Vice President, Diabetes Protein and Peptide Chemistry, Novo Nordisk, Denmark

Shawn Lee, Ph.D., President and CEO, CPC Scientific, USA and China

Paula Lorence, Vice President, Business Development, Avecia OligoMedicines, USA

Bruce Morimoto, Ph.D., Vice President, Drug Development, Allon Therapeutics, Inc., Canada

Takahiro Nakazawa, Ph.D., Senior Director, Research and Development, Anges MG, Inc., Japan

Satoshi Obika, Professor, Graduate School of Pharmaceutical Sciences, Osaka University, Japan

Dmitry Samarsky, Ph.D., Executive Vice President, Technology Development, RiboBio, China

Hideaki Sato, General Manager, Technical Support & Marketing Division, GeneDesign, Inc., Japan

Daisuke Takahashi, Section Chief, Research Institute for Bioscience products and Fine Chemicals, Ajinomoto Co., Inc., Japan

James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc., USA

Blake Unterreiner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc., USA